About: Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.28 (-25.00%)
TCRT NASDAQ Alaunos Therapeutics Inc
Alaunos Therapeutics Inc share price
Atividade de preço de TCRT
Último preço
$ 2,280
Variação (24h)
-0,76 USD (25,00%)
Volume
1.31M
Volume (média 4 sem.)
-
Abertura
$ 2,83
Variação do dia
$ 2,19 - $ 2,86
Fechamento anterior
$ 3,04
Último negócio
23 Oct, 8:28 pm GMT+0
Atrasado
23 Oct, 8:28 pm GMT+0
TCRT price performance
Atrasado
23 Oct, 8:28 pm GMT+0
quote.marketSignals